Page last updated: 2024-11-04

terbutaline and Leukemia

terbutaline has been researched along with Leukemia in 1 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerlo, S1
Vanden Berghe, W1
Verdood, P1
Hooghe-Peters, EL1
Kooijman, R1

Other Studies

1 other study available for terbutaline and Leukemia

ArticleYear
Regulation of prolactin expression in leukemic cell lines and peripheral blood mononuclear cells.
    Journal of neuroimmunology, 2003, Volume: 135, Issue:1-2

    Topics: Adult; Cyclic AMP; Dinoprostone; Gene Expression Regulation; Humans; Ionomycin; Leukemia; Leukocytes

2003